(UNTITLED)

• Document Type: CREST
• Collection: General CIA Records
• Document Number (FOIA) /ESDN (CREST): CIA-RDP80-00810A003600430001-3
• Release Decision: RIPPUB
• Original Classification: C
• Document Page Count: 1
• Document Creation Date: January 12, 2017
• Sequence Number: 1
• Content Type: REPORT

Approved For Release 2006/10/17: CIA-RDP80-00810A003600430001-3'
CENTRAL INTELLIGENCE AGENCY
INFORMATION REPORT
This Document contains information affecting the Na-
tional Defense of the United States. within the mean-
ing of Title 18, Sections 793 and 794. of the U.B. Code, as
amended. Its transmission or revelation of its oontenjs
to or receipt by an unauthorized person is prohibited
by law. The reproduction of this form is prohibited.
CONFIDENTIAL/CONTROL - U.S. OFFICIALS ONLY
COUNTRY China
REPORT NO.
Control of Medical Supplies by the DATE DISTR. February 1951+
Chinese Communists
NO. OF PAGES
REQUIREMENT NO. RD
REFERENCES
25X1 1.
the Chinese Communist authorities had unified the control of the
buying and. the selling of medicines and medical instruments All drug manufactories,
which had been privately operated, were taken over by the government. The Sheng
Hua (3932/0553) Drug Factory,l the largest in Shanghai, had been closed for about
six months, but it was to be reopened on 15 September under government ownership.
a chemical raw material and dye-stuff exchange office (chiao i so,
0074/24-gb/207b] had been established in Shanghai. People who wished to buyLor:.to
sell these products had to register with the exchange office and submit a statement
of the reasons for the transactions.
25X1 1. I iComment, According to Chung Kuo Kung Yeh, Vol. I, No. 11, 1950,
four pharmaceutical plants in Shanghai, among which was a Sheng Hua Factory,
were moved to the interior of China in 19500
CONFIDENTIAL/CONTROL - U.S. OFFICIALS ONLY
Approved For Release 2006/10/17: CIA-RDP80-00810A003600430001-3